EUVIMEDObjevte EUVIMED
Übersichtsarbeit

Synthetic Alternatives to Fetal Bovine Serum: Platforms, Technologies, and Prospects for Industrial Vaccine Production

Sanjay Gottipamula iD, Venkataramana Neelam Krishnan

Biotechnology and Bioengineering · 2026-07-31

DOI: 10.1002/bit.70324 ↗

At a glance

Übersichtsarbeit in Biotechnology and Bioengineering, published online on 2026-07-31. Written by Sanjay Gottipamula and 1 co-authors. Institution: Cell Space Research Centre Pvt. Ltd., Malur, Karnataka, India. Cited 1 times so far (Crossref); 123 references. Funded by: Cell Space Research Center Pvt. Ltd.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Fetal Bovine Serum (FBS) has served as the gold standard supplement in mammalian cell cultures for more than six decades due to its cocktail of growth factors, carrier proteins, hormones, and attachment factors that create an ideal proliferative microenvironment. Nevertheless, heightened regulatory pressure, ethical issues associated with the use of bovine fetuses, logistical challenges, batch‐to‐batch variations, and the risks of contamination by adventitious agents have driven the need to formulate synthetic, animal‐origin‐free (AOF) substitutes. This review examines the key technologies being explored to engineer FBS substitutes, including chemically defined media, recombinant protein fortification using precision fermentation, hydrolyzed plants, human platelet lysates (HPL), conditioned media derived from induced pluripotent stem cells (iPSCs), and genetically engineered microbial cell factories, with special consideration of their feasibility for large‐scale vaccine production in Vero, BHK‐21, HEK293, and MDCK cells. No single technology can presently replace FBS across all applications; however, the convergence of biologics, chemically defined media, and precision fermentation platforms promises to bridge this gap.

Subjects

Author keywords

Fetal bovine serum substituteVero cellindustrial vaccine productionprecision fermentationrecombinant albuminserum‐free mediaviral vaccine manufacturing

Authors and institutions

  • Cell Space Research Centre Pvt. Ltd., Malur, Karnataka, India.
  • Brains Super Speciality Hospital, Bengaluru, Karnataka, India.

ORCID profiles: Sanjay Gottipamula

Funding

  • Cell Space Research Center Pvt. Ltd

Cite

APA

Gottipamula, S., & Neelam Krishnan, V. (2026). Synthetic Alternatives to Fetal Bovine Serum: Platforms, Technologies, and Prospects for Industrial Vaccine Production. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70324

Vancouver

Gottipamula S, Neelam Krishnan V. Synthetic Alternatives to Fetal Bovine Serum: Platforms, Technologies, and Prospects for Industrial Vaccine Production. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70324

BibTeX
@article{Gottipamula2026,
  author = {Gottipamula, Sanjay and Neelam Krishnan, Venkataramana},
  title = {Synthetic Alternatives to Fetal Bovine Serum: Platforms, Technologies, and Prospects for Industrial Vaccine Production},
  journal = {Biotechnology and Bioengineering},
  year = {2026},
  doi = {10.1002/bit.70324}
}
Start for free →